CRS Earnings

CRS reported its earnings on 2026-01-29, showcasing a revenue of 728.00M against an estimate of 729.00M, resulting in a -0.08% surprise. The EPS was 2.33, surpassing the expected 2.2 by 5.91% . The stock experienced a -6.4% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following CRS's earnings announcement on 2026-01-29, the stock price moved by -6.40% on the day of the release. Over the subsequent five days, it saw a % change. Historically, CRS's stock price tends to shift by an average of -3.86% in the 10 days leading up to earnings and +3.22% in the 10 days following, providing insight into potential market.

For 2026/Q3, analysts estimate CRS’s annual revenue to reach 793.00M, while the EPS is projected at 3.00. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 0.02% and EPS estimates No Change by 0% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between CRS's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2026 were Revise Upward by 0.02%, while EPS estimates moved No Change by 0% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, CRS's stock price typically moves by -3.86% in the 10 days before its earnings and +3.22% in the 10 days after. For the upcoming 2026/Q3 earnings, analysts expect an EPS of 3.00 and revenue of 793.00M.

Earnings call highlights include strong future operating income projections, a positive market demand outlook, and substantial price increases in aerospace LTAs. Despite some challenges in medical distribution, the overall sentiment is optimistic, with significant growth in aerospace and energy markets. The Q&A section supports this with expectations of sequential growth in key metrics and improved adoption in the additive business. While some management responses were vague, the overall guidance and positive trends suggest a positive stock price movement.